Immune-mediated neuropathies following stem cell transplantation

Chafic Karam, Michelle L. Mauermann, Patrick B. Johnston, Rajat Lahoria, Ja Nean K. Engelstad, P. James B. Dyck

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Objective: To study the clinical, electrophysiological and pathological characteristics and outcome of immune-mediated neuropathy (IMN) following stem cell transplantation (SCT). Methods: Retrospective chart review of the Mayo Clinic Rochester SCT database between January 1997 and August 2012. Results: Of the 3305 patients who underwent SCT, 12 patients (0.36%) had IMN. The median time from SCT to IMN was 7 months. IMN typically presented as an asymmetric radiculoplexus neuropathy (7/12 patients) or acute polyradiculoneuropathy (Guillain-Barré syndrome) (4/12). Neurophysiology showed demyelinating neuropathy in four patients and axonal neuropathy in eight. Cerebrospinal fluid protein was increased in five of six patients (median 67 mg/dL). The Neuropathy Impairment Score (NIS) improved in all patients (mean NIS 43-10, p=0.016). Six patients died. One patient died from complications of IMN and one died from complications of the haematological disease. Five patients had recurrence of their malignancy within 4 months of the IMN and of these, four died. Conclusions: IMN occurs rarely in patients after SCT. Two possible mechanisms include (1) an immune reconstitution syndrome, supported by stereotypical neuropathy types (radiculoplexus and polyradiculoneuropathies), monophasic course and temporal association with SCT and (2) a paraneoplastic phenomenon, supported by frequent early malignancy recurrence following IMN.

Original languageEnglish (US)
Pages (from-to)638-642
Number of pages5
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume85
Issue number6
DOIs
StatePublished - Jun 1 2014

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Immune-mediated neuropathies following stem cell transplantation'. Together they form a unique fingerprint.

  • Cite this